SARS-CoV-2 variants emerged in late 2020, and at least three variants of concern (B.1.1.7,
B.1.351, and P1) have been reported by WHO. These variants have several substitutions in …

Until recently, the incidence of COVID-19 was primarily estimated using molecular diagnostic
methods. However, the number of cases is vastly underreported using these methods. …

Background Acute respiratory infections are the leading cause of morbidity and mortality
worldwide. Although a viral aetiological agent is estimated to be involved in up to 80% of cases, …

The WHO has approved the use of several vaccines during the COVID-19 pandemic; experience
over the last 2 years has indicated that dose demand can only be covered using more …

The unpredictable, evolutionary nature of the influenza A virus (IAV) is the primary problem
when generating a vaccine and when designing diagnostic strategies; thus, it is necessary to …

SARS-CoV-2 has spread throughout the world since 2019, changing in its genome and
leading to the appearance of new variants. This gave it different evolutionary advantages, such …

Dp40 is the shortest DMD gene product that has been reported to date. It is encoded by
exons 63–70, a region required for a β-dystroglycan interaction. Its expression has been …

Septins are a family of GTP-binding proteins identified in insects and mammals. Septins are
components of the cytoskeleton and participate in cytokinesis, chromosomal segregation, …

SARS-CoV-2 variants have emerged in late 2020 and there are at least three variants of
concern (B.1.1.7, B.1.351, P1) reported by WHO. These variants have several substitutions in …

Background: SARS-CoV-2 is a coronavirus described for the first time in China, in December
2019. This virus can cause a disease with a very variable spectrum that ranges from …